Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women

Marc Sim; Richard L Prince; David Scott; Robin M Daly; Gustavo Duque; Charles A Inderjeeth; Kun Zhu; Richard J Woodman; Jonathan M Hodgson; Joshua R Lewis

doi:10.1016/j.jamda.2018.10.016

Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women

J Am Med Dir Assoc. 2019 Jan;20(1):76-82.e2. doi: 10.1016/j.jamda.2018.10.016. Epub 2018 Dec 6.

Authors

Affiliations

¹ School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical School, Royal Perth Hospital Unit, The University Western Australia, Perth, WA, Australia. Electronic address: marc.sim@ecu.edu.au.
² Medical School, The University Western Australia, Perth, WA, Australia; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
³ Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia; Department of Medicine and Australian Institute of Musculoskeletal Science, Melbourne Medical School-Western Campus, The University of Melbourne, St Albans, VIC, Australia.
⁴ Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia.
⁵ Department of Medicine and Australian Institute of Musculoskeletal Science, Melbourne Medical School-Western Campus, The University of Melbourne, St Albans, VIC, Australia; Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.
⁶ Medical School, The University Western Australia, Perth, WA, Australia.
⁷ Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, SA, Australia.
⁸ School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical School, Royal Perth Hospital Unit, The University Western Australia, Perth, WA, Australia.
⁹ School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical School, Royal Perth Hospital Unit, The University Western Australia, Perth, WA, Australia; Center for Kidney Research, Children's Hospital at Westmead, School of Public Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

PMID: 30527277
DOI: 10.1016/j.jamda.2018.10.016

Abstract

Objectives: To investigate the relationship of 4 sarcopenia definitions with long-term all-cause mortality risk in older Australian women.

Design: Data from the Perth Longitudinal Study in Aging Women from 2003 to 2013 was examined in this prospective cohort study. The 4 sarcopenia definitions were the United States Foundation for the National Institutes of Health (FNIH), the European Working Group on Sarcopenia in Older People (EWGSOP), and adapted FNIH (AUS-POP_F) and EWGSOP (AUS-POP_E) definitions using Australian population-specific cut-points [<2 standard deviation (SD)] below the mean of young healthy Australian women. All-cause mortality was captured via linked data systems.

Setting and participants: In total, 903 community-dwelling older Australian women (baseline mean age 79.9 ± 2.6 years) with concurrent measures of muscle strength (grip strength), physical function (timed-up-and-go; TUG) and appendicular lean mass (ALM) were included.

Measures: Cox-proportional hazards modeling was used to examine the relationship between sarcopenia definitions and mortality over 5 and 9.5 years.

Results: Baseline prevalence of sarcopenia by the 4 definitions differed substantially [FNIH (9.4%), EWGSOP (24.1%), AUS-POP_F (12.0%), AUS-POP_E (10.7%)]. EWGSOP and AUS-POP_E had increased age-adjusted hazard ratios (aHRs) for mortality over 5 years [aHR 1.88 95% confidence interval (CI) (1.24‒2.85), P < .01; aHR 2.52 95% CI (1.55‒4.09), P < .01, respectively] and 9.5 years (aHR 1.39 95% CI (1.06‒1.81), P = .02; aHR 1.94 95% CI (1.40‒2.69), P < .01, respectively). No such associations were observed for FNIH or AUS-POP_F. Sarcopenia components including weaker grip strength (per SD, 4.9 kg; 17%) and slower TUG (per SD, 3.1 seconds; 40%) but not ALM adjusted-variants (ALM/body mass index or ALM/height²) were associated with greater relative hazards for mortality over 9.5 years.

Conclusions/relevance: Unlike FNIH, the EWGSOP sarcopenia definition incorporating weak muscle strength and/or poor physical function was related to prognosis, as was the regionally adapted version of EWGSOP. Although sarcopenia definitions were not developed based on prognosis, this is an important consideration for globally standardizing the sarcopenia framework.

Keywords: Mortality; geriatrics; lean mass; muscle strength; physical function.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Body Composition
Cause of Death
Female
Geriatric Assessment
Hand Strength / physiology
Humans
Longitudinal Studies
Prospective Studies
Sarcopenia / diagnosis
Sarcopenia / mortality
Sarcopenia / physiopathology*
Western Australia / epidemiology